Manulife (Manufacturers Life Insurance)’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1M Buy
441,957
+16,717
+4% +$1.21M 0.03% 485
2026
Q1
$29M Sell
425,240
-1,266
-0.3% -$89.6K 0.02% 506
2025
Q4
$32.4M Buy
426,506
+1,507
+0.4% +$110K 0.03% 507
2025
Q3
$26.1M Buy
424,999
+383,307
+919% +$20M 0.02% 565
2025
Q2
$2.04M Sell
41,692
-1,468
-3% -$69.7K ﹤0.01% 1493
2025
Q1
$2.2M Buy
43,160
+1,586
+4% +$79.1K ﹤0.01% 1450
2024
Q4
$1.88M Sell
41,574
-1,418
-3% -$60.7K ﹤0.01% 1595
2024
Q3
$1.6M Sell
42,992
-804
-2% -$26.9K ﹤0.01% 1669
2024
Q2
$1.34M Buy
43,796
+2,660
+6% +$86.2K ﹤0.01% 1685
2024
Q1
$1.2M Sell
41,136
-24,518
-37% -$687K ﹤0.01% 1760
2023
Q4
$1.81M Sell
65,654
-163
-0.2% -$3.73K ﹤0.01% 1501
2023
Q3
$1.47M Sell
65,817
-15,788
-19% -$587K ﹤0.01% 1538
2023
Q2
$3.32M Buy
81,605
+24,614
+43% +$1.2M ﹤0.01% 1259
2023
Q1
$2.76M Buy
56,991
+10,001
+21% +$457K ﹤0.01% 1310
2022
Q4
$1.77M Sell
46,990
-3,549
-7% -$148K ﹤0.01% 1419
2022
Q3
$2.54M Sell
50,539
-497
-1% -$24.4K ﹤0.01% 1321
2022
Q2
$2.05M Sell
51,036
-435
-0.8% -$15.3K ﹤0.01% 1415
2022
Q1
$1.92M Buy
51,471
+15,969
+45% +$615K ﹤0.01% 1521
2021
Q4
$1.42M Sell
35,502
-194
-0.5% -$7.42K ﹤0.01% 1634
2021
Q3
$1.33M Sell
35,696
-3,379
-9% -$139K ﹤0.01% 1668
2021
Q2
$1.65M Buy
39,075
+4,223
+12% +$181K ﹤0.01% 1691
2021
Q1
$1.65M Sell
34,852
-2,127
-6% -$126K ﹤0.01% 1631
2020
Q4
$2.26M Buy
36,979
+1,299
+4% +$76.6K ﹤0.01% 1483
2020
Q3
$1.67M Sell
35,680
-1,029
-3% -$50.7K ﹤0.01% 1471
2020
Q2
$1.86M Sell
36,709
-1,520
-4% -$74.7K ﹤0.01% 1419
2020
Q1
$1.71M Buy
38,229
+3,893
+11% +$196K ﹤0.01% 1350
2019
Q4
$1.65M Sell
34,336
-1,053
-3% -$44.7K ﹤0.01% 1461
2019
Q3
$1.23M Buy
35,389
+167
+0.5% +$7.27K ﹤0.01% 1555
2019
Q2
$1.58M Buy
35,222
+1,813
+5% +$71.6K ﹤0.01% 1451
2019
Q1
$1.26M Buy
33,409
+5,416
+19% +$182K ﹤0.01% 1581
2018
Q4
$961K Sell
27,993
-1,437
-5% -$51.7K ﹤0.01% 1599
2018
Q3
$1.38M Sell
29,430
-4,011
-12% -$166K ﹤0.01% 1606
2018
Q2
$1.13M Buy
33,441
+3,475
+12% +$108K ﹤0.01% 1792
2018
Q1
$811K Sell
29,966
-942
-3% -$23.9K ﹤0.01% 1974
2017
Q4
$516K Buy
30,908
+36
+0.1% +$609 ﹤0.01% 2301
2017
Q3
$618K Buy
30,872
+4,681
+18% +$91.6K ﹤0.01% 2121
2017
Q2
$479K Sell
26,191
-248
-0.9% -$3.34K ﹤0.01% 2327
2017
Q1
$260K Sell
26,439
-9,514
-26% -$115K ﹤0.01% 2647
2016
Q4
$392K Sell
35,953
-681
-2% -$7.14K ﹤0.01% 2277
2016
Q3
$514K Sell
36,634
-537
-1% -$4.37K ﹤0.01% 2071
2016
Q2
$261K Buy
37,171
+2,321
+7% +$17K ﹤0.01% 2506
2016
Q1
$212K Buy
34,850
+281
+0.8% +$4.88K ﹤0.01% 2556
2015
Q4
$1.12M Buy
34,569
+8,422
+32% +$248K ﹤0.01% 1571
2015
Q3
$698K Buy
26,147
+652
+3% +$27.9K ﹤0.01% 1786
2015
Q2
$1.23M Buy
25,495
+5,229
+26% +$305K ﹤0.01% 1577
2015
Q1
$1.23M Buy
20,266
+785
+4% +$47.9K ﹤0.01% 1565
2014
Q4
$1.01M Buy
19,481
+737
+4% +$32.4K ﹤0.01% 1579
2014
Q3
$825K Buy
18,744
+147
+0.8% +$4.6K ﹤0.01% 1677
2014
Q2
$487K Buy
18,597
+2,346
+14% +$50.2K ﹤0.01% 2057
2014
Q1
$425K Buy
16,251
+8,514
+110% +$229K ﹤0.01% 2192
2013
Q4
$131K Buy
7,737
+7,574
+4,647% +$133K ﹤0.01% 2959
2013
Q3
$3K Buy
+163
New +$2.83K ﹤0.01% 3470

Other funds holding PTCT

Manulife (Manufacturers Life Insurance)'s PTCT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its PTC Therapeutics (PTCT) stake by 3.9% in Q2 2026, buying an estimated $1.21M and bringing the position to 441,957 shares worth $36.1M. The position accounts for 0.03% of the portfolio, ranked #485.

Manulife (Manufacturers Life Insurance) first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 441,957 shares of PTC Therapeutics worth $36.1M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 16,717 PTC Therapeutics shares in Q2 2026, an estimated $1.21M.
  • PTC Therapeutics made up 0.03% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #485 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.